Moreover, pan-cancer analysis reveals that trNK cell involvement is associated with better patient survival across a number of solid tumors and supports the potential utility of a combination regimen comprising ionizing radiation (IR) and CCR5i/αPD1 IT as a promising strategy to increase NK/cDC1/CD8-mediated tumor control in solid cancers. The gene discussed is CD8A; the disease is neoplasm.